Nosox Classic (Oxymetazoline Hydrochloride)

Oxymetazoline, the active ingredient in Nosox Classic, is an alpha‑adrenergic agonist presented as a nasal decongestant for nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children.

GNH USA supplies Nosox Classic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance.

Nosox Classic, an alpha‑adrenergic nasal decongestant, is employed to alleviate congestion in several upper‑respiratory conditions.

- Common cold: reduces swelling of nasal mucosa, improving airflow and easing breathing. - Sinusitis: diminishes mucosal edema, helping to clear blocked sinuses and relieve pressure. - Allergic rhinitis: lessens congestion caused by allergic inflammation, allowing better nasal patency.

Oxymetazoline may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing or mild headache.

Serious or Rare Side Effects: - Rebound nasal congestion (rhinitis medicamentosa) with prolonged use. - Elevated blood pressure or tachycardia. - Severe allergic reaction such as angioedema or anaphylaxis.

Before using Nosox Classic, consider the following safety measures.

- Do not exceed recommended frequency: limit to two doses within a 24‑hour period. - Avoid use in children under six years of age: safety has not been established. - Consult a healthcare professional if nasal symptoms persist longer than three days. - Use with caution in patients with hypertension or other cardiovascular disorders. - Avoid concomitant use with other sympathomimetic nasal products. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Oxymetazoline may interact with other medications; awareness of these interactions helps minimize risk.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other nasal decongestants: additive vasoconstrictive effects may increase local irritation. - Systemic sympathomimetic agents: may amplify cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: possible reduction in blood‑pressure‑lowering effect. - Beta‑blockers: may lead to increased heart rate. - Tricyclic antidepressants: potential for additive sympathomimetic activity.